DOVONEX

This brand name is authorized in United States. It is also authorized in Canada, Ireland, Japan, Malta, South Africa, UK.

Active ingredients

The drug DOVONEX contains one active pharmaceutical ingredient (API):

1	Calcipotriol UNII 143NQ3779B - CALCIPOTRIENE
	Calcipotriol is a derivative of vitamin D for topical use on psoriasis. It probably works by suppressing keratinization. Advantage of substance or absence of odor and non-coloring of clothing.
	Read more about Calcipotriol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
Dovonex Ointment	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D05AX02	Calcipotriol	D Dermatologicals → D05 Antipsoriatics → D05A Antipsoriatics for topical use → D05AX Other antipsoriatics for topical use
Discover more medicines within D05AX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	01976133
GB	Medicines & Healthcare Products Regulatory Agency	201303, 30768, 381297
IE	Health Products Regulatory Authority	68910, 68990
JP	医薬品医療機器総合機構	2691701M1031
MT	Medicines Authority	MA1313/00301
US	FDA, National Drug Code	50222-260
ZA	Health Products Regulatory Authority	29/13.9.1/0270, 29/13.9.1/0762, Z/13.9.1/207